Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D01977 | Gefitinib (JP18/USAN/INN) | Iressa (TN) | Non-small cell lung cancer (EGFR mutation positive) [DS:H00014] |
| D03455 |
Cetuximab (USAN/INN) Cetuximab (genetical recombination) (JAN) |
Erbitux (TN) |
Squamous cell carcinoma of the head and neck [DS:H02420] Colorectal cancer (K-Ras wild type, EGFR-expressing) [DS:H00020] Colorectal cancer (BRAF mutation positive) [DS:H00020] |
| D04023 | Erlotinib hydrochloride (JAN/USAN) | Tarceva (TN) |
Non-small cell lung cancer (EGFR mutation positive) [DS:H00014] Pancreatic cancer [DS:H00019] |
| D09371 |
Ramucirumab (USAN) Ramucirumab (genetical recombination) (JAN) |
Cyramza (TN) |
Gastric cancer [DS:H00018] Non-small cell lung cancer (EGFR exon 19 deletions or exon 21 (L858R) substitution mutated) [DS:H00014] Colorectal cancer [DS:H00020] Hepatocellular carcinoma [DS:H00048] |
| D09733 |
Afatinib dimaleate (USAN) Afatinib maleate (JAN) |
Gilotrif (TN) Giotrif (TN) |
Non-small cell lung cancer (EGFR mutation positive) [DS:H00014] |
| D10514 |
Dacomitinib (USAN) Dacomitinib hydrate (JAN) |
Vizimpro (TN) | Non-small cell lung cancer (EGFR mutation positive) [DS:H00014] |
| D10766 |
Osimertinib mesylate (USAN) Osimertinib mesilate (JAN) |
Tagrisso (TN) | Non-small cell lung cancer (EGFR mutation positive) [DS:H00014] |
| D11894 |
Amivantamab (USAN/INN) Amivantamab (genetical recombination) (JAN) Amivantamab-vmjw |
Rybrevant (TN) | Non-small cell lung cancer (EGFR exon 20 insertion) [DS:H00014] |
| D11969 | Mobocertinib succinate (JAN) | Exkivity (TN) | Non-small cell lung cancer (EGFR exon 20 insertion mutation) [DS:H00014] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |